Drug delivery systems

Handbook of Biodegradable Polymers: Isolation, Synthesis, Characterization and Applications

Volumn , Issue , 2011, Pages 363-378

  Shakesheff, Kevin M ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Biodegradable polymers; Drug delivery systems; Extracellular matrix (ECM); Polyanhydrides; Polymer drug conjugate; Water in oil (W O) emulsion

Indexed keywords

EID: 84865204853     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527635818.ch15     Document Type: Chapter

References (42)

1. Langer, R. (1990) New methods of drug delivery. Science, 249, (4976), 1527-1533.
2. Weinberg, B.D., Blanc, E., and Ga, J.M. (2008) Polymer implants for intratumoral drug delivery and cancer therapy. J. Pharm. Sci., 97 (5), 1681-1702.
3. Kim, H.K., Chung, H.J., and Park, T.G. (2006) Biodegradable polymeric microspheres with " open/closed " pores for sustained release of human growth hormone. J. Control Release, 112 (2), 167-174.
4. DelMoral, P.F., Dijkman, G.A., Debruyne, F.M.J., Witjes, W.P.J., and Kolvenbag, G. (1996) Three.-month depot of goserelin acetate: clinical effi cacy and endocrine profi le. Urology, 48 (6), 894-900.
5. Attenello, F.J., Mukherjee, D., Datoo, G., McGirt, M.J., Bohan, E., Weingart, J.D., Olivi, A., Quinones.-Hinojosa, A., and Brem, H. (2008) Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10.-year institutional experience. A nn. Surg. Oncol., 15 (1 0), 2887-2893.
6. Brem, S., Tyler, B., Pradilla, G., K.L., Legnani, F., Caplan, J., Brem, and H. (2007) Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model. Cancer Chemother. Pharmacol., 60 (5), 643-650
7. Wang, P.P., J. Frazier, and H. Brem (2002) Local drug delivery to the brain. Adv. Drug Deliv. Rev., 54 (7), 987-1013.
8. Anderson, J.M. and Shive, M.S. (1997) Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev., 28 (1), 5-24.
9. Li, S.M., Garreau, H., and Vert, M. (1990) Structure property relationships in the case of the degradation of massive poly(alpha.-hydroxy acids) in aqueous media. 2. Degradation of lactide-glycolide copolymers-PLA37.5GA25 and PLA75GA25. J. Mater. Sci. Mater. Med., 1 (3), 131-139.
10. Beck, L.R., Pope, V.Z., Flowers, C.E., Cowsar, D.R., Tice, T.R., Lewis, D.H., Dunn, R.L., Moore, A.B., and Gilley, R.M. (1983) Poly(DL.-lactide.-co.-glycolide) norethisterone microcapsules-an injectable biodegradable contraceptive. Biol. Reprod., 28 (1), 186-195.
11. Li, S.M. and Vert, M. (1994) Morphological.-changes resulting from the hydrolytic degradation of stereocopolymers derived from L.-lactides and DL.-lactides. Macromolecules, 27 (11), 3107-3110.
12. Vert, M. (1986) Biomedical polymers from chiral lactides and functional lactones-properties and applications. Macromol. Chem. Macromol. Symp., 6, 109-122.
13. Vert, M. (2007) Polymeric biomaterials: strategies of the past vs. strategies of the future. Progr. Polym. Sci., 32 (8-9), 755-761.
14. Vert, M., Li, S.M., Spenlehauer, G., and Guerin, P. (1992) Bioresorbability and biocompatibility of aliphatic polyesters. J. Mater. Sci. Mater. Med., 3 (6), 432-446.
15. Grizzi, I., Garreau, H., Vert, M., and S.L. (1995) Hydrolytic degradation of devices based on poly(DL.-lactic acid) size-dependence. Biomaterials, 16 (4), 305-311.
16. Katti, D.S., S. Lakshmi, R. Langer, and C.T. Laurencin (2002) Toxicity, biodegradation and elimination of polyanhydrides. Adv. Drug Deliv. Rev., 54 (7), 933-961.
17. Leong, K.W., Brott, B.C., and Langer, R. (1985) Bioerodible polyanhydrides as drug.-carrier matrices. 1. Characterization, degradation, and release characteristics. J. Biomed. Mater. Res., 19 (8), 941-955.
18. Cleland, J.L., Johnson, O.L., Putney, S., and Jones, A.J.S. (1997) Recombinant human growth hormone poly(lactic.-co-glycolic acid) microsphere formulation development. Adv. Drug Deliv. Rev., 28 (1), 71-84.
19. Morita, T., Sakamura, Y., Horikiri, Y., Suzuki, T., and Yoshino, H. (2000) Protein encapsulation into biodegradable microspheres by a novel S/O/W emulsion method using poly(ethylene glycol) as a protein micronization adjuvant. J. Control. Release, 69 (3), 435-444.
20. Ghalanbor, Z., Korber, M., and Bodmeier, R. (2010) Improved lysozyme stability and release properties of poly(lactide.-co.-glycolide) implants prepared by hot.-melt extrusion. Pharm. Res., 27 (2), 371-379.
21. Gualandi, C., White, L.J., Chen, L., Gross, R.A., Shakesheff, K.M., Howdle, S.M., and Scandola, M. (2010) Scaffold for tissue engineering fabricated by non.-isothermal supercritical carbon dioxide foaming of a highly crystalline polyester. A cta Biomater., 6 (1), 130-136.
22. Davies, O.R., Lewis, A.L., Whitaker, M.J., Tai, H.Y., Shakesheff, K.M., and Howdle, S.M. (2008) Applications of supercritical CO 2 in the fabrication of polymer systems for drug delivery and tissue engineering. Adv. Drug Deliv. Rev., 60 (3), 373-387.
23. Whitaker, M.J., Hao, J.Y., Davies, O.R., Serhatkulu, G., Stolnik.-Trenkic, S., Howdle, S.M., and Shakesheff, K.M. (2005) The production of protein.-loaded microparticles by supercritical fl uid enhanced mixing and spraying. J. Control. Release, 101 (1-3), 85-92
24. Sy, J.C., Seshadri, G., Yang, S.C., Brown, M., Dikalov, S., T.O., Murthy, N., Davis, and M.E. (2008) Sustained release of a p38 inhibitor from non.-infl ammatory microspheres inhibits cardiac dysfunction. Nat. Mater., 7 (11), 863-869.
25. Lutolf, M.P. and J.A. Hubbell (2005) Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. N at. Biotechnol., 23 (1),-55.
26. Kraehenbuehl, T.P., Zammaretti, P., Van der Vlies, A.J., Schoenmakers, R.G., Lutolf, M.P., Jaconi, M.E., and Hubbell, J.A. (2008) Three.-dimensional extracellular matrix.-directed cardioprogenitor differentiation: systematic modulation of a synthetic cell.-responsive PEG.-hydrogel. Biomaterials, 29 (18), 2757-2766.
27. Redhead, H.M., Davis, S.S., and Illum, L. (2001) Drug delivery in poly(lactide.-co-glycolide) nanoparticles surface modifi ed with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J. Control. Release, 70 (3), 353-363.
28. Stolnik, S., Heald, C.R., Neal, J., Garnett, M.C., Davis, S.S., Illum, L., Purkis, S.C., Barlow, R.J., and Gellert, P.R. (2001) Polylactide.-poly(ethylene glycol) micellar.-like particles as potential drug carriers: production, colloidal properties and biological performance. J. Drug Target., 9 (5), 361-378.
29. Riley, T., Stolnik, S., Heald, C.R., Xiong, C.D., Garnett, M.C., Illum, L., Davis, S.S., Purkiss, S.C., Barlow, R.J., and Gellert, P.R. (2001) Physicochemical evaluation of nanoparticles assembled from poly(lactic acid).-poly(ethylene glycol) (PLA.-PEG) block copolymers as drug delivery vehicles. Langmuir, 17 (11), 3168-3174.
30. Dunn, S.E., Brindley, A., Davis, S.S., Davies, M.C., and Illum, L. (1994) Polystyrene.-poly(ethylene glycol) (ps.-peg2000) particles as model systems for site.-specifi c drug.-delivery. 2. The effect of PEG surface.-density on the in.-vitro cell.-interaction and in.-vivo biodistribution. Pharm. Res., 11 (7), 1016-1022.
31. Gref, R., Minamitake, Y., Peracchia, M.T., Trubetskoy, V., Torchilin, V., and Langer, R. (1994) Biodegradable long.-circulating polymeric nanospheres. Science, 263, 1600-1603.
32. Rothenfluh, D.A., Bermudez, H., O'Neil, C.P., and Hubbell, J.A. (2008) Biofunctional polymer nanoparticles for intra.-articular targeting and retention in cartilage. N at. Mater., 7 (3), 248-254.
33. Grayson, A.C.R., Choi, I.S., Tyler, B.M., Wang, P.P., Brem, H., Cima, M.J., and Langer, R. (2003) Multi.-pulse drug delivery from a resorbable polymeric microchip device. Nat. Mater., 2 (11), 767-772.
34. Park, J..-H., Allen, M.G., and Prausnitz, M.R. (2006) Polymer microneedles for controlled.-release drug delivery. Pharm. Res., 23, 1008.-1019.
35. Ringsdorf, H. (1975) Structure and properties of pharmacologically active polymers. J. Polym. Sci. Symp., 51, 135-153.
36. Gros, L., Ringsdorf, H., and Schupp, H. (1981) Polymer antitumour agents on a molecular and on a cellular level? Angew. Chem. Int. Ed. Engl., 20, 305-325.
37. Jain, A. and Duncan, S.K. (2008) Jain, PEGylation: an approach for drug delivery. A review. Crit. Rev. Ther. Drug Carrier Syst., 25 (5), 403-447.
38. Duncan, R. (2007) Designing polymer conjugates as lysosomotropic nanomedicines. B iochem. Soc. Trans., 35,-60.
39. Zentner, G.M., Rathi R., Shih C., McRea J.C., Seo M.-H., Oh, H., Rhee B.G., Mestecky J., Moldoveanu Z., Morgan M., and Weitman, S. (2001) Biodegradable block copolymers for delivery of proteins and water.-insoluble drugs. J. Control. Release, 72, 203-215.
40. Elstad, N.L. and Fowers, K.D. (2009) OncoGel (ReGel/paclitaxel)-Clinical applications for a novel paclitaxel delivery system. Adv. Drug Deliv. Rev., 61 (10), 785-794.
41. Langer, R. and Tirrell, D.A. (2004) Designing materials for biology and medicine. N ature, 428 (6 982), 487-492.
42. Shen, W., Zhang, K.C., Kornfield, J.A., and Tirrell, D.A. (2006) Tuning the erosion rate of artifi cial protein hydrogels through control of network topology. Nat. Mater., 5 (2), 153-158.